, Pentadecapeptide BPC 157 and the central nervous system, Medknow, 2022
Animals with combined esophagitis, sphincter failure, and pancreatitis showed improvement across all conditions with BPC-157 treatment
The formulation includes BPC-157, a 15amino acid pentadecapeptide derived from a protective peptide sequence identified in human gastric juice, and TB-500, a synthetic peptide derived from thymosin beta-4, a naturally occurring actin-regulating protein present in many mammalian tissues
Yes, our research-grade BPC-157 is suitable for various laboratory applications, including in vitro, ex vivo, and approved in vivo studies
This uncertainty further complicates any assessment of combined use